Notably, prognostic analysis demonstrated that this expression pattern (higher EHMT2 expression and lower PTEN expression) was correlated with poorer overall survival than other expression patterns in patients with NSCLC (Fig. 6c), data consistent with those in the PROGgeneV2 database (GSE30219, Fig. 6d). Here, EHMT2 is linked to non-small cell lung carcinoma.